About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Massachusetts | 1,146 Studies

Clinical Trials Breast CancerMassachusetts

Breast Cancer Clinical Trials in Massachusetts

Find 1,146 clinical trials for breast cancer near Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 1,146 trials

CompletedData Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/LetrozoleThis study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and…NCT05635357·Boston, Massachusetts Active not recruitingTrastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]This study will compare DS-8201a to physician choice standard treatment. Participants must have HER2-low breast cancer that has been treated before.NCT03734029·Chandler, Arizona and 207 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00015938·Mobile, Alabama and 98 others

CompletedEribulin in HER2 Negative Metastatic BrCaImprovements in outcomes with metastatic breast cancer (MBC) have been observed in the last 30 years, however, overall prognosis remains poor with median survival of 2 to 3 years.NCT01827787·Bangor, Maine and 6 others

CompletedRadiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Estrogen can stimulate the growth of breast cancer cells.NCT00003857·Mobile, Alabama and 368 others

CompletedCabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesThis research study is evaluating the effectiveness of the drug called cabozantinib (alone or in combination with trastuzumab) as a possible treatment for advanced breast cancer…NCT02260531·Boston, Massachusetts and 1 other

RecruitingComparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsThe over-arching goal of the Contrast-Enhanced Spectral Mammography Imaging Screening Trial (CMIST) is to determine if dual-energy contrast-enhanced spectral mammography (CESM)…NCT05625659·Birmingham, Alabama and 12 others

CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum dose of LDE225 and BKM120 that can be safely given together to patients and/or the dose that will be used in future studies.NCT01576666·Los Angeles, California and 22 others

TerminatedPhase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BCThis research study is studying radiation therapy in combination with an immunotherapy as a possible treatment for metastatic hormone receptor (HR) positive, HER2-negative breast…NCT03051672·Boston, Massachusetts

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

CompletedWeight Management Among Breast Cancer SurvivorsThe long-term goal of this research is to develop, evaluate and implement effective mHealth technology interventions that improve cancer management outcomes by changing lifestyle…NCT02387671·Boston, Massachusetts

CompletedA Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerThis two-cohort, open-label, multicenter, phase 2 study will assess the safety and efficacy of pertuzumab given in combination with trastuzumab (Herceptin) and vinorelbine in…NCT01565083·Tucson, Arizona and 79 others

CompletedA Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the BodyThe reason for this study is to determine the recommended phase 2 dose of the study drug LY3295668 erbumine in participants with breast cancer that has spread to other parts of…NCT03955939·Duarte, California and 6 others

CompletedPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesThe purpose of this study of MCS110 with PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of the…NCT02807844·Boston, Massachusetts and 19 others

TerminatedA Study of Varlilumab and Atezolizumab in Patients With Advanced CancerThis is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining varlilumab and atezolizumab.NCT02543645·San Francisco, California and 3 others

Active not recruitingDAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BCThis research study is studying whether participants and their doctors are willing to determine post-surgery treatment on the basis of response to pre-surgery treatment, and…NCT03716180·Boston, Massachusetts and 4 others

CompletedSWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002900·Mobile, Alabama and 104 others

RecruitingThe LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated LymphedemaThe aim of this study is to test whether lymphatic surgery provides better QoL (assessed with the Lymph-ICF-UL, (Lymphedema Functioning Disability and health questionnaire for…NCT05890677·New Haven, Connecticut and 35 others

CompletedA Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryThis trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with estrogen receptor positive/ human epidermal growth factor receptor 2…NCT05549505·Springdale, Arkansas and 48 others

CompletedA Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast CancerThis study will determine whether the investigational drug dasatinib is effective in treatment of women with progressive advanced triple-negative breast cancer.NCT00371254·San Francisco, California and 9 others

PreviousPage 4 of 58Next

Other Conditions in Massachusetts

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma